Perrigo Co PLC (PRGO): Revenue
$4.25B
Year ended 2025-12-31
$4.14B
Trailing 12 months to 2026-06-27
-1.5%
3-year compound annual growth
+0.8%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.25B | -2.8% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $4.37B | -6.1% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $4.66B | +4.6% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $4.45B | +7.6% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $4.14B | +1.2% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $4.09B | +5.6% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $3.87B | n/c | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $4.73B | -4.3% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $4.95B | -6.3% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $5.28B | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2015-06-27 and 2016-12-31. | |||
| 2015-06-27 | $4.23B | +8.0% | 2018-03-01, From 2014-06-29 |
| 2014-06-28 | $3.91B | n/c | 2017-05-22, From 2013-06-30 |
| 2013-06-29 | $3.54B | +11.6% | 2015-08-13, From 2012-07-01 |
| 2012-06-30 | $3.17B | n/a | 2014-08-14, From 2011-06-26 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Perrigo Co PLC (PRGO) | 2025-12-31 | $4.25B | -2.8% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.27B | +4.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $4.71B | +6.2% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $3.71B | +65.2% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $5.34B | +40.2% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $3.22B | +12.9% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $3.18B | +10.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.02B | +8.0% |
| Organon & Co. (OGN) | 2025-12-31 | $6.22B | -2.9% |
Compare PRGO, JAZZ, ELAN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗